Evommune and Axcelead Drug Discovery Partners Launch A Collaboration On A PKCtheta Program To Kick-off Evommune’s Inflammation Pipeline
Inhibition of PKCtheta as a therapeutic target has the potential to treat multiple inflammatory diseases ...
Axcelead and Kyowa Kirin Started an Innovative Collaboration in Small-Molecule Drug Development
Tokyo, Japan, October 2, 2020 —Axcelead Drug Discovery Partners Inc.(Axcelead, President: Yoshinori Ikeura)and Kyowa Kirin Co., Ltd....
Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications
June 29,2020- Otsuka Pharmaceutical Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, President: Makoto Inoue; Otsuka Pharmaceutical) and Axcelead Drug...